185 related articles for article (PubMed ID: 12849117)
1. Supratentorial grade II astrocytoma: biological features and clinical course.
Wessels PH; Weber WE; Raven G; Ramaekers FC; Hopman AH; Twijnstra A
Lancet Neurol; 2003 Jul; 2(7):395-403. PubMed ID: 12849117
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
Ständer M; Peraud A; Leroch B; Kreth FW
Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of supratentorial astrocytoma WHO grade II.
Peraud A; Ansari H; Bise K; Reulen HJ
Acta Neurochir (Wien); 1998; 140(12):1213-22. PubMed ID: 9932120
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a clinically distinct new subtype of grade II astrocytomas in patients with long-term epilepsy.
Schramm J; Luyken C; Urbach H; Fimmers R; Blümcke I
Neurosurgery; 2004 Aug; 55(2):340-7; discussion 347-8. PubMed ID: 15271240
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between IDH1 mutation and prognosis in supratentorial high-grade astrocytomas].
Xie F; Tang JJ; Wang X; Liu YH; Mao Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Mar; 44(2):184-7, 192. PubMed ID: 23745251
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
Peraud A; Kreth FW; Wiestler OD; Kleihues P; Reulen HJ
Clin Cancer Res; 2002 May; 8(5):1117-24. PubMed ID: 12006527
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis.
Jungk C; Scherer M; Mock A; Capper D; Radbruch A; von Deimling A; Bendszus M; Herold-Mende C; Unterberg A
J Neurooncol; 2016 Sep; 129(2):319-28. PubMed ID: 27344556
[TBL] [Abstract][Full Text] [Related]
9. Low-grade glioma: supratentorial astrocytoma, oligodendroglioma, and oligoastrocytoma in adults.
Ashby LS; Shapiro WR
Curr Neurol Neurosci Rep; 2004 May; 4(3):211-7. PubMed ID: 15102347
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous malignant transformation of a supratentorial pilocytic astrocytoma.
Otero-Rodríguez A; Sarabia-Herrero R; García-Tejeiro M; Zamora-Martínez T
Neurocirugia (Astur); 2010 Jun; 21(3):245-52. PubMed ID: 20571729
[TBL] [Abstract][Full Text] [Related]
11. Role of early radiotherapy in the treatment of supratentorial WHO Grade II astrocytomas: long-term results of 97 patients.
Hanzély Z; Polgár C; Fodor J; Brucher JM; Vitanovics D; Mangel LC; Afra D
J Neurooncol; 2003 Jul; 63(3):305-12. PubMed ID: 12892238
[TBL] [Abstract][Full Text] [Related]
12. Aberrant p53 expression does not correlate with the prognosis in anaplastic astrocytoma.
Danks RA; Chopra G; Gonzales MF; Orian JM; Kaye AH
Neurosurgery; 1995 Aug; 37(2):246-54. PubMed ID: 7477776
[TBL] [Abstract][Full Text] [Related]
13. Management of supratentorial low-grade gliomas.
Shaw EG; Scheithauer BW; O'Fallon JR
Oncology (Williston Park); 1993 Jul; 7(7):97-104, 107; discussion 108-11. PubMed ID: 8347464
[TBL] [Abstract][Full Text] [Related]
14. Supratentorial high-grade astrocytoma with leptomeningeal spread to the fourth ventricle: a lethal dissemination with dismal prognosis.
Li M; Ren X; Jiang H; Yang K; Huang W; Yu K; Chen H; Dong G; Cui Y; Lin S
J Neurooncol; 2019 Apr; 142(2):253-261. PubMed ID: 30604394
[TBL] [Abstract][Full Text] [Related]
15. Low grade supratentorial astrocytomas. Management and prognostic factors.
Janny P; Cure H; Mohr M; Heldt N; Kwiatkowski F; Lemaire JJ; Plagne R; Rozan R
Cancer; 1994 Apr; 73(7):1937-45. PubMed ID: 8137221
[TBL] [Abstract][Full Text] [Related]
16. Supratentorial low-grade diffuse astrocytoma: medical management.
Ajlan A; Recht L
Semin Oncol; 2014 Aug; 41(4):446-457. PubMed ID: 25173138
[TBL] [Abstract][Full Text] [Related]
17. The impact of tumour volume and surgery on the outcome of adults with supratentorial WHO grade II astrocytomas and oligoastrocytomas.
Mariani L; Siegenthaler P; Guzman R; Friedrich D; Fathi AR; Ozdoba C; Weis J; Ballinari P; Seiler RW
Acta Neurochir (Wien); 2004 May; 146(5):441-8. PubMed ID: 15118879
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms.
Montine TJ; Vandersteenhoven JJ; Aguzzi A; Boyko OB; Dodge RK; Kerns BJ; Burger PC
Neurosurgery; 1994 Apr; 34(4):674-8; discussion 678-9. PubMed ID: 8008166
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of loss of O6-methylguanine-DNA methyltransferase expression in supratentorial diffuse low-grade astrocytoma.
Nakasu S; Fukami T; Jito J; Matsuda M
Surg Neurol; 2007 Dec; 68(6):603-608. PubMed ID: 17825378
[TBL] [Abstract][Full Text] [Related]
20. Interstitial 125I radiosurgery of supratentorial de novo WHO Grade 2 astrocytoma and oligoastrocytoma in adults: long-term results and prognostic factors.
Kreth FW; Faist M; Grau S; Ostertag CB
Cancer; 2006 Mar; 106(6):1372-81. PubMed ID: 16470609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
